Leilei Chen
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Etiological stratification and prognostic assessment of haemophagocytic lymphohistiocytosis by machine learning on onco-mNGS data and clinical data.
Journal: Frontiers in immunology
Published: February 23, 2024
Lymphocytes in Patients with Chronic Active Epstein-Barr Virus Disease Exhibited Elevated PD-1/PD-L1 Expression and a Prevailing Th2 Immune Response.
Journal: Mediterranean journal of hematology and infectious diseases
Published: November 12, 2023
PD-1 Blockade-Induced Hemophagocytic Lymphohistiocytosis, a Dilemma Therapeutic Outcome in 2 Patients with CAEBV: A Case Series.
Journal: Infection and drug resistance
Published: October 20, 2023
Chronic active Epstein-Barr virus disease originates from infected hematopoietic stem cells.
Journal: Blood
Published: May 09, 2023
PD-1 blockade and lenalidomide combination therapy for chronic active Epstein-Barr virus infection.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: June 16, 2022
L-DEP regimen is effective as an initial therapy for adult EBV-HLH.
Journal: Annals of hematology
Published: May 19, 2022
Safety and efficacy of low-dose ticagrelor in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Journal: Platelets
Published: April 05, 2021
Non-EBV infection-associated hemophagocytic lymphohistiocytosis: a distinct subgroup where pathogen-directed therapy is essential and favorable outcomes are expected.
Journal: Leukemia & lymphoma
Published: February 15, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026